GNH USA

Europe — EMA

Nitisinone Logixx Pharma

GNH USA supplies Nitisinone Logixx Pharma (Nitisinone), a 4‑hydroxyphenylpyruvate dioxygenase inhibitor for hereditary tyrosinemia type I.

Request sourcing

1
Pack/s

What is Nitisinone?

Nitisinone, the active ingredient in Nitisinone Logixx Pharma, is a 4‑hydroxyphenylpyruvate dioxygenase (HPPD) inhibitor presented as an oral tablet for oral use. It treats hereditary tyrosinemia type I in affected patients.

GNH USA supplies Nitisinone Logixx Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

What is Nitisinone used for?

Nitisinone acts on the tyrosine degradation pathway and is indicated for hereditary tyrosinemia type I. - Hereditary tyrosinemia type I: reduces accumulation of toxic metabolites, improves liver function and supports metabolic control.

What are the side effects of Nitisinone?

Nitisinone may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Headache: mild to moderate intensity. - Nausea: occasional, may improve with food. - Vomiting: transient episodes. - Abdominal pain: mild discomfort. - Fatigue: generalized tiredness. - Skin rash: erythematous or pruritic lesions.

Serious or Rare Side Effects: - Hepatic failure: signs of jaundice or elevated liver enzymes. - Seizures: especially in patients with metabolic instability. - Severe hypoglycemia: low blood sugar requiring monitoring. - Peripheral neuropathy: tingling or numbness in extremities. - Acute pancreatitis: abdominal pain with elevated enzymes. - Anaphylaxis: rapid onset of airway swelling or hypotension.

What precautions apply to Nitisinone?

Before initiating therapy, clinicians should consider several safety measures. - Liver monitoring: perform baseline and periodic liver function tests. - Tyrosine levels: regularly assess plasma tyrosine to avoid excess. - Hypersensitivity: discontinue if allergic reactions occur. - Pregnancy: use only if potential benefit justifies risk, as safety is unknown. - Renal impairment: adjust dosing and monitor renal function. - Store at room temperature: keep in the original pack, protect from moisture.

What does Nitisinone interact with?

Nitisinone can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Vitamin A supplements: may increase risk of hepatotoxicity. - Other HPPD inhibitors: additive inhibition of the pathway. - High‑protein diets rich in tyrosine: can counteract therapeutic effect.

Moderate Interactions (Monitor Closely): - CYP450 inducers (e.g., rifampicin): may reduce plasma concentrations. - Anticoagulants (e.g., warfarin): monitor INR for potential changes. - Anticonvulsants (e.g., carbamazepine): observe for altered seizure control.

Frequently asked questions

What is Nitisinone Logixx Pharma used for?+
Nitisinone Logixx Pharma is used to treat hereditary tyrosinemia type I, a rare metabolic disorder. By inhibiting the HPPD enzyme, it prevents the buildup of toxic metabolites that can damage the liver, kidneys and other organs.
How does Nitisinone work in the body?+
Nitisinone blocks the enzyme 4‑hydroxyphenylpyruvate dioxygenase (HPPD) in the tyrosine degradation pathway. This stops the formation of downstream toxic compounds such as succinylacetone, thereby reducing metabolic toxicity and protecting organ function.
What is the usual dose of Nitisinone Logixx Pharma?+
The dose of Nitisinone Logixx Pharma is individualized by the prescribing clinician based on the patient’s age, weight, disease severity and laboratory parameters. Dosage adjustments are made according to therapeutic response and safety monitoring.
Is Nitisinone safe during pregnancy or breastfeeding?+
Safety of Nitisinone in pregnancy and lactation has not been established. It should only be used if the potential benefit outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.
How do I order Nitisinone Logixx Pharma from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Nitisinone compare with other treatments for hereditary tyrosinemia type I?+
Nitisinone is the primary disease‑modifying therapy for hereditary tyrosinemia type I, directly targeting the metabolic defect. Alternative options such as liver transplantation address organ failure but do not correct the underlying metabolic pathway. Nitisinone therefore offers a less invasive, long‑term management strategy.
What are the recommended storage conditions for Nitisinone Logixx Pharma?+
Store the product at room temperature, below 25 °C, in its original packaging. Keep it away from moisture, direct sunlight and excessive heat to maintain stability and potency.
How is Nitisinone Logixx Pharma administered?+
Nitisinone Logixx Pharma is taken orally, usually as a tablet, with or without food as directed by the prescriber. The exact administration schedule is determined by the treating physician.
What are the most serious risks associated with Nitisinone therapy?+
Serious risks include hepatic failure, severe hypoglycemia, seizures, peripheral neuropathy, acute pancreatitis and anaphylactic reactions. Patients should be monitored regularly for signs of these events, and therapy should be discontinued if they occur.
Who should not use Nitisinone Logixx Pharma?+
Patients with known hypersensitivity to nitisinone or any excipients, those with uncontrolled liver disease, and individuals for whom the risk of therapy outweighs the benefit should avoid using the product. Clinical judgment is essential.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Nitisinone
Route
Oral Use
Manufacturer
Logixx Pharma Ltd
Origin
EU

Related products